Journal of Cancer Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Mini Review - Journal of Cancer Clinical Research (2023) Volume 6, Issue 1

Rectal cancer after a complete response to chemoradiotherapy.

Rectal cancer is a type of cancer that develops in the rectum, which is the last part of the large intestine before the anus. Chemo radiotherapy is a common treatment for rectal cancer, which involves a combination of chemotherapy and radiation therapy. In some cases, patients with rectal cancer may achieve a complete response to chemo radiotherapy, which means that there is no evidence of cancer remaining after treatment. However, even after a complete response, there is still a risk of cancer recurrence. A study published in the journal JAMA Oncology in 2021 analyzed the risk of cancer recurrence in patients with rectal cancer who achieved a complete response to chemo radiotherapy. The study included 485 patients who underwent chemo radiotherapy for rectal cancer and achieved a complete response.

Author(s): George William

Abstract Full Text PDF

Get the App